BRCA1 and breast carcinoma: For BRCA1 heterozygotes, the HR per SD for the association between the ER-negative PRS313 and breast cancer was 1.29, 95% CI (1.25–1.33),24 compared with 1.12, 95% CI (1.06–1.18) for contralateral breast cancer in this study.